|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
03/22/2024 |
$5.21 |
$5.25 |
$4.90 |
$5.05 |
159.40K | 03/25/2024 |
$5.11 |
$5.23 |
$4.93 |
$5.08 |
129.30K | 03/26/2024 |
$5.15 |
$5.18 |
$5.02 |
$5.04 |
51.50K | 03/27/2024 |
$5.12 |
$5.12 |
$4.91 |
$5.01 |
100.90K | 03/28/2024 |
$4.96 |
$5.37 |
$4.96 |
$5.24 |
80.50K |
|
Eagle Pharmaceuticals is an integrated pharmaceutical company with research and development, clinical, manufacturing and commercial capabilities. Co.'s products and product portfolio include: BARHEMSYS® (amisulpride for injection), which is for the treatment of postoperative nausea and vomiting; BYFAVO® (remimazolam for injection), which is indicated for the induction and maintenance of procedural sedation; bendamustine ready-to-dilute (RTD) 500ml solution, infused bendamustine RTD, and bendamustine RTD and infused RTD in Japan for Chronic Lymphocytic Leukemia and Non-Hodgkin's Lymphoma; Ryanodex® (dantrolene sodium) for Malignant Hyperthermia; and EA-114 (fulvestrant) for breast cancer. | |
|
Eagle Pharmaceuticals (EGRX) has the following price history information. Looking back at EGRX historical stock prices for the last five trading days, on March 22, 2024, EGRX opened at $5.21, traded as high as $5.25 and as low as $4.90, and closed at $5.05. Trading volume was a total of 159.40K shares. On March 25, 2024, EGRX opened at $5.11, traded as high as $5.23 and as low as $4.93, and closed at $5.08. Trading volume was a total of 129.30K shares. On March 26, 2024, EGRX opened at $5.15, traded as high as $5.18 and as low as $5.02, and closed at $5.04. Trading volume was a total of 51.50K shares. On March 27, 2024, EGRX opened at $5.12, traded as high as $5.12 and as low as $4.91, and closed at $5.01. Trading volume was a total of 100.90K shares. On March 28, 2024, EGRX opened at $4.96, traded as high as $5.37 and as low as $4.96, and closed at $5.24. Trading volume was a total of 80.50K shares.
EGRX Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Eagle Pharmaceuticals shares, starting with a $10,000 purchase of EGRX, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/01/2014 |
|
End date: |
03/28/2024 |
|
Start price/share: |
$12.90 |
|
End price/share: |
$5.24 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-59.38% |
|
Average Annual Total Return: |
-8.62% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$4,060.87 |
|
Years: |
10.00 |
|
|
|
Date |
Close |
03/22/2024 | $5.05 | 03/25/2024 | $5.08 | 03/26/2024 | $5.04 | 03/27/2024 | $5.01 | 03/28/2024 | $5.24 |
|
|